[
    [
        {
            "time": "2021-12-01",
            "original_text": "华兰生物部分高管合计减持72.397万股，减持计划期限已届满，拟减持股份。",
            "features": {
                "keywords": [
                    "华兰生物",
                    "高管",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物部分高管合计减持72.397万股，减持计划期限已届满，拟减持股份。",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "华兰生物：部分高管合计减持0.0397%股份，减持计划期限届满，拟减持股份。",
            "features": {
                "keywords": [
                    "华兰生物",
                    "高管",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物：部分高管合计减持0.0397%股份，减持计划期限届满，拟减持股份。",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "华兰生物：7名高管减持期届满，合计减持72.4万股，减持股份。",
            "features": {
                "keywords": [
                    "华兰生物",
                    "高管",
                    "减持",
                    "股份"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华兰生物：7名高管减持期届满，合计减持72.4万股，减持股份。",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "最强风口大分化！5000亿龙头透露重磅信息，却遭资金砸盘20亿，冷门股锐奇股份5天大涨62%。",
            "features": {
                "keywords": [
                    "龙头",
                    "资金砸盘",
                    "冷门股",
                    "锐奇股份",
                    "大涨"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "其他行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "最强风口大分化！5000亿龙头透露重磅信息，却遭资金砸盘20亿，冷门股锐奇股份5天大涨62%。",
                "Correlation": 2,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "疫苗销售费用大增，千亿疫苗股陷子公司分拆上市“阴谋论”。",
            "features": {
                "keywords": [
                    "疫苗",
                    "销售费用",
                    "子公司",
                    "分拆上市",
                    "阴谋论"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "疫苗销售费用大增，千亿疫苗股陷子公司分拆上市“阴谋论”。",
                "Correlation": 6,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "一文了解2020年第三季度中国血液制品行业及细分产品市场竞争格局分析。",
            "features": {
                "keywords": [
                    "血液制品",
                    "市场竞争",
                    "2020年第三季度"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "一文了解2020年第三季度中国血液制品行业及细分产品市场竞争格局分析。",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 4
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "医药行业2021年投资策略：“双循环”背景下，“创新升级＋进口替代”引领医药大时代。",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资策略",
                    "双循环",
                    "创新升级",
                    "进口替代"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2021年投资策略：“双循环”背景下，“创新升级＋进口替代”引领医药大时代。",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "药企分拆成热潮，科创板、创业板成“香饽饽”。",
            "features": {
                "keywords": [
                    "药企分拆",
                    "科创板",
                    "创业板"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "药企分拆成热潮，科创板、创业板成“香饽饽”。",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "2020Q3血制品批签发数据跟踪报告：Q3单季度出现下滑，Q1-Q3仍维持增长。",
            "features": {
                "keywords": [
                    "血制品",
                    "批签发",
                    "Q3",
                    "下滑",
                    "增长"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "2020Q3血制品批签发数据跟踪报告：Q3单季度出现下滑，Q1-Q3仍维持增长。",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        }
    ]
]